Metabolic changes in early neonatal life: NMR analysis of the neonatal metabolic profile to monitor postnatal metabolic adaptations.


Journal

Metabolomics : Official journal of the Metabolomic Society
ISSN: 1573-3890
Titre abrégé: Metabolomics
Pays: United States
ID NLM: 101274889

Informations de publication

Date de publication:
24 04 2020
Historique:
received: 02 12 2019
accepted: 15 04 2020
entrez: 26 4 2020
pubmed: 26 4 2020
medline: 11 3 2021
Statut: epublish

Résumé

A major challenge from the moment a child is delivered is the adaptation to the extrauterine life, where rapid metabolic changes take place. The study of these changes during the first days of human life may assist in the understanding of the metabolic processes that occur at this critical period, which is likely to provide significant clinical insights. To date, metabolomics has become a powerful field, ideal for the monitoring of such dynamic variations, since it offers the possibility to identify alterations in metabolic profiles, even on daily basis. The study included 253 healthy newborns (GA 35 to 40 weeks) from the region of Western Greece. Urine samples were collected immediately after birth and at the third day of life. NMR-based metabolomics was used to compare the metabolic urinary profiles of newborns from the first and third day of their life, assessing the impact of six perinatal factors; delivery mode, prematurity, maternal smoking, gender, nutrition and neonatal jaundice. Analysis of urine metabolic fingerprint from the first and third day of life, coupled with multivariate statistics, provides insights into the details of early life metabolic profile differentiation. Αt the third day of life metabolic adaptations are evident, as many differences were noted in urine of healthy neonates within the first 72 h postpartum. Trends in differentiation of metabolites levels between the two groups, late preterm and term newborns, have been also observed. Newborn's urine metabolic profiles confirmed the rapid changes in their metabolism after birth. Further, ongoing research will enable us to develop one reference model of urinary metabolomics in healthy newborns during the period of adaptation to the extra-uterine life.

Sections du résumé

BACKGROUND
A major challenge from the moment a child is delivered is the adaptation to the extrauterine life, where rapid metabolic changes take place. The study of these changes during the first days of human life may assist in the understanding of the metabolic processes that occur at this critical period, which is likely to provide significant clinical insights. To date, metabolomics has become a powerful field, ideal for the monitoring of such dynamic variations, since it offers the possibility to identify alterations in metabolic profiles, even on daily basis.
METHODS
The study included 253 healthy newborns (GA 35 to 40 weeks) from the region of Western Greece. Urine samples were collected immediately after birth and at the third day of life. NMR-based metabolomics was used to compare the metabolic urinary profiles of newborns from the first and third day of their life, assessing the impact of six perinatal factors; delivery mode, prematurity, maternal smoking, gender, nutrition and neonatal jaundice.
RESULTS
Analysis of urine metabolic fingerprint from the first and third day of life, coupled with multivariate statistics, provides insights into the details of early life metabolic profile differentiation. Αt the third day of life metabolic adaptations are evident, as many differences were noted in urine of healthy neonates within the first 72 h postpartum. Trends in differentiation of metabolites levels between the two groups, late preterm and term newborns, have been also observed.
CONCLUSIONS
Newborn's urine metabolic profiles confirmed the rapid changes in their metabolism after birth. Further, ongoing research will enable us to develop one reference model of urinary metabolomics in healthy newborns during the period of adaptation to the extra-uterine life.

Identifiants

pubmed: 32333120
doi: 10.1007/s11306-020-01680-4
pii: 10.1007/s11306-020-01680-4
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

58

Références

Clin Chim Acta. 2015 Dec 7;451(Pt A):28-34
pubmed: 26279361
Ann Hum Biol. 2008 Nov-Dec;35(6):573-83
pubmed: 18932054
Front Biosci (Elite Ed). 2011 Jun 01;3:1005-12
pubmed: 21622109
Am J Public Health. 1989 Feb;79(2):158-62
pubmed: 2913833
J Matern Fetal Neonatal Med. 2014 Oct;27 Suppl 2:13-9
pubmed: 25284172
Clin Biochem. 2010 Jun;43(9):732-44
pubmed: 20346934
Adv Nutr. 2015 Sep 15;6(5):564-71
pubmed: 26374178
PLoS One. 2016 Feb 25;11(2):e0149823
pubmed: 26914934
J Am Coll Nutr. 1998 Aug;17(4):379-84
pubmed: 9710849
Int J Vitam Nutr Res. 2004 May;74(3):193-8
pubmed: 15296078
Food Nutr Bull. 2002 Sep;23(3):244-7
pubmed: 12362586
J Hum Cap. 2011 Summer;5(2):207-254
pubmed: 22272363
J Matern Fetal Neonatal Med. 2014 Apr;27(6):537-42
pubmed: 23844701
PLoS One. 2013 Jul 03;8(7):e67223
pubmed: 23843995
J Proteome Res. 2016 Oct 7;15(10):3712-3723
pubmed: 27650928
J Proteome Res. 2015 Apr 3;14(4):1799-809
pubmed: 25722016
Am J Physiol Endocrinol Metab. 2015 May 15;308(10):E921-7
pubmed: 25805190
Int J Mol Sci. 2016 Feb 22;17(2):265
pubmed: 26907266
Dev Neuropsychol. 2009;34(1):1-36
pubmed: 19142764
Medicine (Baltimore). 2016 Apr;95(17):e3564
pubmed: 27124067
Benef Microbes. 2017 Oct 13;8(5):763-778
pubmed: 29022384
Metabolomics. 2016;12:76
pubmed: 27065762
Br Med Bull. 2001;60:5-20
pubmed: 11809615
Acta Paediatr Suppl. 2006 Apr;450:76-85
pubmed: 16817681
Arch Dis Child Fetal Neonatal Ed. 1995 Nov;73(3):F153-7
pubmed: 8535871
J Proteome Res. 2017 Oct 6;16(10):3732-3740
pubmed: 28791867
J Proteome Res. 2016 Jan 4;15(1):311-25
pubmed: 26566167
Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11971-5
pubmed: 20566857
J Proteome Res. 2017 Jun 2;16(6):2262-2272
pubmed: 28440083
J Econ Perspect. 2011 Summer;25(3):153-172
pubmed: 25152565
Lancet. 1986 May 10;1(8489):1077-81
pubmed: 2871345
J Pediatr Endocrinol Metab. 2017 Aug 28;30(9):939-946
pubmed: 28777736
Biosci Rep. 2015 Sep 17;35(5):
pubmed: 26381576
Nutrients. 2015 Sep 18;7(9):8020-35
pubmed: 26393648
Int J Clin Exp Med. 2015 Sep 15;8(9):16454-62
pubmed: 26629171
JIMD Rep. 2014;16:101-11
pubmed: 25012580
Nutrients. 2014 May 12;6(5):1913-30
pubmed: 24824288
Minerva Pediatr. 2010 Jun;62(3 Suppl 1):145-8
pubmed: 21089734
Clin Chem Lab Med. 2013 Mar 1;51(3):571-8
pubmed: 23241677
Eur J Pediatr. 2000 Mar;159(3):198-204
pubmed: 10664235
Int J Mol Sci. 2016 Jul 20;17(7):
pubmed: 27447622
Clin Transl Sci. 2016 Aug;9(4):216-20
pubmed: 27306191
Microbiome. 2018 Apr 20;6(1):73
pubmed: 29678198
Sci Rep. 2017 Apr 04;7:45506
pubmed: 28374757
J Matern Fetal Neonatal Med. 2011 Oct;24 Suppl 2:35-9
pubmed: 21767100
Nutr Hosp. 2002 Nov-Dec;17(6):262-70
pubmed: 12514918
Biol Neonate. 1990;58(6):334-42
pubmed: 2288995
MAGMA. 2006 Dec;19(6):305-12
pubmed: 17136356
Int J Tryptophan Res. 2013 Jul 21;6(Suppl 1):3-8
pubmed: 23922498
Rev Endocr Metab Disord. 2012 Jun;13(2):109-19
pubmed: 22418620
J Matern Fetal Neonatal Med. 2013 Nov;26(16):1649-52
pubmed: 23570570
Early Hum Dev. 2014 Mar;90 Suppl 1:S78-83
pubmed: 24709468
Nat Rev Mol Cell Biol. 2008 Feb;9(2):151-61
pubmed: 18216771
Nutr Metab Insights. 2015 Dec 16;8(Suppl 1):1-9
pubmed: 26715853
Obstet Gynecol Sci. 2014 Mar;57(2):109-14
pubmed: 24678483
Acta Med Okayama. 1991 Apr;45(2):101-6
pubmed: 1867111
Clin Chim Acta. 1988 Dec 30;178(3):241-9
pubmed: 3240600

Auteurs

Ioanna Georgakopoulou (I)

Department of Pharmacy, University of Patras, 26504, Patras, Greece.

Styliani A Chasapi (SA)

Department of Pharmacy, University of Patras, 26504, Patras, Greece.

Steve E Bariamis (SE)

Department of Pharmacy, University of Patras, 26504, Patras, Greece.

Anastasia Varvarigou (A)

Department of Paediatrics, University of Patras Medical School, General University Hospital, Patras, Greece. varvarigou@upatras.gr.

Manfred Spraul (M)

Bruker BioSpin, Silberstreifen, 76287, Rheinstetten, Germany.

Georgios A Spyroulias (GA)

Department of Pharmacy, University of Patras, 26504, Patras, Greece. G.A.Spyroulias@upatras.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH